• Approved News

Otsuka Pharmaceutical：VoyxactSibeprenlimab was approved through the priority review process.

• Approved News

Jiangsu Beijietai：Bemiltenase Alfa approved for marketing in China

• Approved News

Innovent：IBI343 has been formally accepted for review.

• Drug news

How much does Dupixent (Dupilumab Injection) Cost& price without insurance in China?

• Drug news

How much does Evrysdi (Risdiplam powder for oral solution) Cost& price without insurance in China?

• Drug news

How much does TEVIMBRA (Tislelizumab Injection) Cost& price without insurance in China?

• Drug news

How much does Akeega (Niraparib Tosylate and Abiraterone Acetate Tablets) Cost& price without insurance in China?

• Drug news

How much does Meiyouheng (Becotatug Vedotin for Injection) Cost& price without insurance in China?

• Drug news

How much does Rhapsido (Remibrutinib Tablets) Cost& price without insurance in China?

• Drug news

How much does Myqorzo (Aficamten Tablets) Cost& price without insurance in China?

• Drug news

How much does Inlyta (Axitinib Tablets) Cost& price without insurance in China?

• Drug news

How much does Jakavi (Ruxolitinib Phosphate Tablets) Cost& price without insurance in China?